How to buy Capitol Health shares

Own Capitol Health shares in just a few minutes.

We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!

Capitol Health Limited is a medical care facilities business based in Australia. Capitol Health shares (CAJ) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Capitol Health has a trailing 12-month revenue of around $158.5 million. If you're looking to buy shares, check out the steps below.

How to buy shares in Capitol Health

  1. Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
  3. Search for Capitol Health. Find the share by name or ticker symbol: CAJ. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Capitol Health reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
  6. Check in on your investment. Congratulations, you own a part of Capitol Health. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Capitol Health share price

Use our graph to track the performance of CAJ stocks over time.

Capitol Health shares at a glance

Information last updated 2021-06-18.
52-week range$0.1952 - $0.375
50-day moving average $0.3581
200-day moving average $0.3209
Target price$0.36
PE ratio 86.25
Dividend yield $0.01 (2.94%)
Earnings per share (TTM) $0.004

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
Name Product Standard brokerage fee Inactivity fee Markets
Superhero share trading
AUD $5
ASX shares, ETFs
Pay zero brokerage on all Australian ETFs.
Trade ASX stocks with a flat $5 commission fee and a low minimum investment of just $100.
Bell Direct Share Trading
Finder AwardExclusive
Bell Direct Share Trading
AUD $15
ASX shares, mFunds, ETFs
⭐ Finder Exclusive: Get 5 free stock trades and unlimited ETF trades until July 31, 2021 when you join Bell Direct.
Bell Direct offers a one-second placement guarantee on market-to-limit ASX orders or your trade is free, plus enjoy extensive free research reports from top financial experts.
IG Share Trading
Finder Award
IG Share Trading
AUD $8 or 0.1%
$50 per quarter if you make fewer than three trades in that period
ASX shares, Global shares
$0 brokerage for US and global shares plus get an active trader discount of $5 commission on Australian shares.
Enjoy some of the lowest brokerage fees on the market when trading Australian shares, international shares, plus get access to 24-hour customer support.
Saxo Capital Markets (Classic account)
AUD $6.99
ASX shares, Global shares, Forex, CFDs, Margin trading, Options trading, ETFs
Acess 19,000+ stocks on 37 exchanges worldwide
Low fees for Australian and global share trading, no inactivity fees, low currency conversion fee and optimised for mobile.
CMC Markets Stockbroking
AUD $11 or 0.1%
ASX shares, Global shares, mFunds, ETFs
$0 brokerage on global shares including US, UK and Japan markets.
Trade up to 9,000 products, including shares, ETFs and managed funds, plus access up to 15 major global and Australian stock exchanges.

Compare up to 4 providers

Is it a good time to buy Capitol Health stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Capitol Health price performance over time

Historical closes compared with the last close of A$0.355

1 week (2021-06-18) 2.90%
1 month (2021-05-25) -1.39%
3 months (2021-03-25) 5.97%
6 months (2020-12-24) 29.09%
1 year (2020-06-25) 47.92%
2 years (2019-06-25) 69.05%
3 years (2018-06-25) 7.58%
5 years (2016-06-24) 129.03%

Is Capitol Health under- or over-valued?

Valuing Capitol Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Capitol Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Capitol Health's P/E ratio

Capitol Health's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 86x. In other words, Capitol Health shares trade at around 86x recent earnings.

That's relatively high compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Capitol Health's EBITDA

Capitol Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $32.1 million.

The EBITDA is a measure of a Capitol Health's overall financial performance and is widely used to measure a its profitability.

Capitol Health financials

Revenue TTM $158.5 million
Operating margin TTM 15.77%
Gross profit TTM $40.7 million
Return on assets TTM 6.17%
Return on equity TTM 3.57%
Profit margin 2.8%
Book value 0.141
Market capitalisation $354.6 million

TTM: trailing 12 months

Capitol Health share dividends


Dividend payout ratio: 100% of net profits

Recently Capitol Health has paid out, on average, around 100% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.94% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Capitol Health shareholders could enjoy a 2.94% return on their shares, in the form of dividend payments. In Capitol Health's case, that would currently equate to about A$0.01 per share.

Capitol Health's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.

The latest dividend was paid out to all shareholders who bought their shares by 3 March 2021 (the "ex-dividend date").

Have Capitol Health's shares ever split?

Capitol Health's shares were split on 19 October 2009.

Capitol Health share price volatility

Over the last 12 months, Capitol Health's shares have ranged in value from as little as $0.1952 up to $0.375. A popular way to gauge a stock's volatility is its "beta".

CAJ.AU volatility(beta: 0.87)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Capitol Health's is 0.8712. This would suggest that Capitol Health's shares are less volatile than average (for this exchange).

Capitol Health overview

Capitol Health Limited provides diagnostic imaging and related services to the healthcare market in Australia. The company owns and operates clinics in Victoria, Tasmania, and Western Australia. It offers a range of diagnostic imaging services, including general x-ray, magnetic resonance imaging, ultrasound, mammography, Doppler, orthopantomogram, echocardiography, computed tomography, CT angiography, cone beam CT, nuclear medicine, bone densitometry, and fluoroscopy. The company was founded in 2005 and is headquartered in East Melbourne, Australia.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs comes with a higher risk of losing money rapidly due to leverage. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder only provides general advice and factual information, so consider your own circumstances, or seek advice before you decide to act on our content. By submitting a question, you're accepting our Terms of Use, Disclaimer & Privacy Policy and Privacy & Cookies Policy.
Go to site
Not sure what platform to go with?
Take this quick quiz to find the right share trading platform